pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Fentanyl
drug
save

fentanyl ER

Marketedupdated 5mo ago
by Actavis Elizabeth LLC
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval674 co-mentions · 246 sources
  • drugfentanyl CR641 co-mentions · 294 sources
  • drugFENTANYL-75641 co-mentions · 294 sources
  • drugfentanyl641 co-mentions · 294 sources
  • drugFENTANYL-37641 co-mentions · 294 sources
  • drugActiq240 co-mentions · 183 sources
  • drugSUBLIMAZE PRESERVATIVE FREE238 co-mentions · 183 sources
  • drugEffentora234 co-mentions · 183 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 30 investigational indications.

all catalysts(54)

approval · 51
Jan 28, 2005
approval
$NIU1.8800+1.62%
22y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
May 4, 2005
approval
$NIU1.8800+1.62%
21y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Sep 6, 2005
approval
$NIU1.8800+1.62%
21y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Jan 23, 2007
approval
$NIU1.8800+1.62%
20y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Jan 23, 2007
approval
$NIU1.8800+1.62%
20y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
May 20, 2008
approval
$NIU1.8800+1.62%
18y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Feb 9, 2011
approval
16y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Jul 9, 2012
approval
14y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Jul 9, 2012
approval
$NIU1.8800+1.62%
14y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Jul 9, 2012
approval
$NIU1.8800+1.62%
14y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Jul 9, 2012
approval
14y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Jul 10, 2012
approval
$NIU1.8800+1.62%
14y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Apr 15, 2013
approval
13y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Apr 15, 2013
approval
$NIU1.8800+1.62%
13y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Jun 16, 2014
approval
12y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Jun 20, 2014
approval
$NIU1.8800+1.62%
12y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Aug 19, 2014
approval
$NIU1.8800+1.62%
12y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Aug 19, 2014
approval
12y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Jun 11, 2015
approval
11y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Jun 26, 2015
approval
$NIU1.8800+1.62%
11y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Jun 26, 2015
approval
11y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Jul 8, 2015
approval
$NIU1.8800+1.62%
11y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Apr 20, 2016
approval
10y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Apr 20, 2016
approval
$NIU1.8800+1.62%
10y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Sep 30, 2016
approval
$NIU1.8800+1.62%
10y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Sep 30, 2016
approval
10y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
May 26, 2017
approval
$NIU1.8800+1.62%
9y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
May 26, 2017
approval
9y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Sep 18, 2018
approval
8y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Sep 18, 2018
approval
$NIU1.8800+1.62%
8y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
May 6, 2020
approval
6y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
May 6, 2020
approval
6y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
May 6, 2020
approval
6y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
May 6, 2020
approval
6y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
May 6, 2020
approval
6y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 8, 2023
approval
3y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 14, 2023
approval
$NIU1.8800+1.62%
3y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 14, 2023
approval
$NIU1.8800+1.62%
3y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 14, 2023
approval
$NIU1.8800+1.62%
3y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 14, 2023
approval
$NIU1.8800+1.62%
3y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 14, 2023
approval
$NIU1.8800+1.62%
3y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 15, 2023
approval
3y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 15, 2023
approval
$NIU1.8800+1.62%
3y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 15, 2023
approval
3y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Oct 31, 2024
approval
$NIU1.8800+1.62%
2y ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Oct 31, 2024
approval
2y ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 22, 2025
approval
10mo ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 22, 2025
approval
$NIU1.8800+1.62%
10mo ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 22, 2025
approval
10mo ago
FENTANYL-75 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 22, 2025
approval
$NIU1.8800+1.62%
10mo ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
Dec 22, 2025
approval
$NIU1.8800+1.62%
10mo ago
FENTANYL-37 (FENTANYL) — FDA approval
fentanyl ER
→
phase 2 completion · 2
Apr 27, 2026
phase 2 completion
5mo ago
Konya City Hospital — fentanyl (Phase II Trial Completion)
fentanyl ER
→
Apr 28, 2026
phase 2 completion
5mo ago
KS Hegde Medical Academy — fentanyl (Phase II Trial Completion)
fentanyl ER
→
phase iv trial initiation · 1
Apr 26, 2026
phase iv trial initiation
5mo ago
Kalpana Chawla Government Medical College — fentanyl (Phase IV Trial Initiation)
fentanyl ER
→
view all 54 catalysts →

Trials studying fentanyl ER

  • phase2A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockadenot yet recruitingn=16
  • N/AIntercostal Nerve Cryoablation Versus Epidural Analgesia for Nuss Repair of Pectus Excavatumcompletedn=50
  • phase4Premedication for Less Invasive Surfactant Administration Study (PRELISA)completedn=58
  • phase1A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumorsrecruitingn=100
  • phase1Buprenorphine-Fentanyl Interaction Studycompletedn=22
  • phase1Bioequivalence Study of Fentanyl Transdermal System (JNJ-35685-AAA-G021) Compared With DURAGESIC Fentanyl Transdermal Patch in Healthy Participantscompletedn=56
  • phase1A Study to Evaluate the Adherence of 2 Strengths of Newly Manufactured Samples and Aged Samples of a New Formulation (JNJ-35685-AAA-G016 and JNJ-35685-AAA-G021) of Fentanyl Transdermal System Compared With Duragesic Fentanyl Transdermal Patch in Healthy Participantscompletedn=52
  • phase4Programmed Intermittent Epidural Bolus (PIEB) Techniques for Labour Analgesiacompletedn=136

Patent cliff

source: FDA Orange Book
first barrier falls
Jan 25, 2027
112 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (68)

  • Apr 27, 2030formulationUS 84869723.6y
  • Apr 27, 2030formulationUS 84869723.6y
  • Apr 27, 2030formulationUS 84869723.6y
  • Apr 27, 2030formulationUS 84869723.6y
  • Apr 27, 2030formulationUS 84869723.6y
  • Apr 27, 2030formulationUS 84869723.6y
  • Apr 27, 2030formulationUS 84869723.6y
  • Apr 27, 2030method-of-use (U-55)US 84869733.6y
  • Apr 27, 2030method-of-use (U-55)US 84869733.6y
  • Apr 27, 2030method-of-use (U-55)US 84869733.6y
  • Apr 27, 2030method-of-use (U-55)US 84869733.6y
  • Apr 27, 2030method-of-use (U-55)US 84869733.6y
  • Apr 27, 2030method-of-use (U-55)US 84869733.6y
  • Apr 27, 2030method-of-use (U-55)US 84869733.6y
  • Jan 25, 2027formulationUS 10016403112d
  • Jan 25, 2027formulationUS 10016403112d
  • Jan 25, 2027formulationUS 10016403112d
  • Jan 25, 2027formulationUS 10016403112d
  • Jan 25, 2027formulationUS 10016403112d
  • Jan 25, 2027formulationUS 10016403112d
  • Jan 25, 2027formulationUS 10016403112d
  • Jan 25, 2027formulationUS 10610523112d
  • Jan 25, 2027formulationUS 10610523112d
  • Jan 25, 2027formulationUS 10610523112d
  • Jan 25, 2027formulationUS 10610523112d
  • Jan 25, 2027formulationUS 10610523112d
  • Jan 25, 2027formulationUS 10610523112d
  • Jan 25, 2027formulationUS 10610523112d
  • Jan 25, 2027formulationUS 8835459112d
  • Jan 25, 2027formulationUS 8835459112d
  • Jan 25, 2027formulationUS 8835459112d
  • Jan 25, 2027formulationUS 8835459112d
  • Jan 25, 2027formulationUS 8835459112d
  • Jan 25, 2027formulationUS 8835460112d
  • Jan 25, 2027formulationUS 8835460112d
  • Jan 25, 2027formulationUS 8835460112d
  • Jan 25, 2027formulationUS 8835460112d
  • Jan 25, 2027formulationUS 8835460112d
  • Jan 25, 2027formulationUS 8835460112d
  • Jan 25, 2027formulationUS 8835460112d
  • Jan 25, 2027formulationUS 9241935112d
  • Jan 25, 2027formulationUS 9241935112d
  • Jan 25, 2027formulationUS 9241935112d
  • Jan 25, 2027formulationUS 9241935112d
  • Jan 25, 2027formulationUS 9241935112d
  • Jan 25, 2027formulationUS 9241935112d
  • Jan 25, 2027formulationUS 9241935112d
  • Jan 25, 2027formulationUS 9289387112d
  • Jan 25, 2027formulationUS 9289387112d
  • Jan 25, 2027formulationUS 9289387112d
  • Jan 25, 2027formulationUS 9289387112d
  • Jan 25, 2027formulationUS 9289387112d
  • Jan 25, 2027formulationUS 9289387112d
  • Jan 25, 2027formulationUS 9289387112d
  • Jan 25, 2027formulationUS 9642797112d
  • Jan 25, 2027formulationUS 9642797112d
  • Jan 25, 2027formulationUS 9642797112d
  • Jan 25, 2027formulationUS 9642797112d
  • Jan 25, 2027formulationUS 9642797112d
  • Jan 25, 2027formulationUS 9642797112d
  • Jan 25, 2027formulationUS 9642797112d
  • Jan 25, 2027formulationUS 9642844112d
  • Jan 25, 2027formulationUS 9642844112d
  • Jan 25, 2027formulationUS 9642844112d
  • Jan 25, 2027formulationUS 9642844112d
  • Jan 25, 2027formulationUS 9642844112d
  • Jan 25, 2027formulationUS 9642844112d
  • Jan 25, 2027formulationUS 9642844112d

News(10)

  • Kratom and 7-OH should be regulated, experts agree. They’re split on how
    Kratom has skirted regulation for decades, but newer, highly concentrated 7-OH products have renewed interest in safeguards.
    stat · 4d ago
  • One of the most contagious diseases on the planet is having its worst U.S. outbreak since 1991
    The CDC has added a single measles death to its online counter. In the last few weeks, four unvaccinated people have died from measles in Pennsylvania, according to state officials.…
    stat · 10d ago
  • The latest in the legal saga for youth gender-affirming care in the U.S.
    The chilling effect of the Trump administration's dogged offensive against transgender health care has been swift, with dozens of hospitals across the U.S. ending care, even if they haven't been…
    stat · 11d ago
  • New federal autism committee head has financial ties to leucovorin
    RFK Jr. has installed John Gaitanis, a pediatric neurologist, as the new chair of the Interagency Autism Coordinating Committee, which helps the federal government decide how to allocate roughly $2…
    stat · 12d ago
  • President Trump’s newest vaccine ‘demands’ repeat old misinformation
    A day after health secretary Robert F. Kennedy Jr. promised that parents concerned about vaccines had a “friend” in the White House, President Trump said he’ll be “demanding” that drug…
    stat · 13d ago
  • Addiction clinics see rising cases of kratom and 7-OH withdrawal
    Addiction clinics are seeing a surge in patients dependent on potent kratom and 7-OH products.
    stat · 13d ago
  • Who supports policies for ‘health equity’? It depends on how you’re asking
    Kennedy speaks at the Children's Health Defense, medical facilities under attack in Sudan, and more health news from Morning Rounds
    stat · 16d ago
  • STAT+: Why do ‘never-smokers’ get lung cancer? In some cases, rare genetic variant may be a factor
    Researchers have identified a very rare genetic variant that is associated with higher odds of lung cancer in "never smokers."
    stat · 17d ago
  • Purer fentanyl won’t solve the U.S. overdose death crisis, study says
    Cautious optimism in the Ebola outbreak, FDA still stymied by DOGE cuts, and other health updates from the Morning Rounds newsletter.
    stat · 17d ago
  • U.S. reaches highest number of measles deaths in decades
    How the midterms could change health care, the sedative contaminating the fentanyl black market, and other health news from Morning Rounds
    stat · 18d ago
view all news mentions →
brand
Fentanyl
generic
fentanyl
MOA
Mu opioid receptor agonist
indication
Cancer Pain
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 1h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?